The US funder of two projects that created a highly pathogenic flu virus mutation has welcomed a two-month moratorium on further research while defending the value and safety of the experiments.
Office of Strategic Communication
The US funder of two projects that created a highly pathogenic flu virus mutation has welcomed a two-month moratorium on further research while defending the value and safety of the experiments.